Cosmo Smith on How Origin Improves Patient Access

Video

In Partnership With:

P. Cosmo Smith, managing partner, Origin Commercial Ventures, discusses how Origin improves patient access in oncology.

P. Cosmo Smith, managing partner, Origin Commercial Ventures, discusses how Origin improves patient access in oncology.

Patients go to health systems for access to novel therapeutics, explains Smith, which is why Origin decided to partner with Atlantic Health. As Origin moves forward, they hope to embody a similar culture as that of Atlantic Health by providing access to the therapies that have the best chance of success to the greatest number of patients, says Smith.

Enabling that success is not an insignificant barrier, explains Smith. There needs to be a level of both excitement within the parent institutions as well as financial creativity. One of the missions at Atlantic Health is to create better therapeutic access to patients by looking at new insurance and payer structures. This is where Origin comes in, as they are heavily involved in those regards on an industry-wide basis. The goal, says Smith, is to have a variety of available health plans and carve out programs that allow patients access to the treatment they need when they need it.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD